Original Report

Quality of supportive care for patients with advanced lung cancer in the Veterans Health Administration


 

Background Morbidity related to cancer and its treatment remains a significant source of human suffering and a challenge to the delivery of high-quality care.

Objective To develop and apply quality indicators to evaluate quality of supportive care for advanced lung cancer in the Veterans Health Administration (VHA) and examine facility-level predictors of quality.

Methods We evaluated supportive care quality using 12 quality indicators. Data were taken from VHA electronic health records for incident lung cancer cases occurring during 2007. Organizational characteristics of 111 VHA facilities were examined for association with receipt of care.

Results Rates of care-receipt were high, especially in the treatment toxicity (89%) and pain management (79%-98%) domains, but were lower in the palliative cancer treatment (60%-90%) and hospice (75%) domains, with substantial facility- level variation. Presence of a care tracking method that was monitored by a midlevel practitioner seemed to be associated with better quality for treatment toxicity (OR, 3.38; 95% CI, 1.87-6.10) and referral to hospice (OR, 1.60; 95% CI, 1.22-2.28); having a psychologist for cancer patients was associated with higher odds for pain management (OR, 1.76; 95% CI, 1.16-2.66).

Limitations Not all supportive care was evaluated. Care processes identified as present at facilities may not have been applied to cohort patients. Facility-level results may be influenced by errors in attributing a patient’s care to the correct facility.

Conclusions Quality indicators for supportive cancer care can be developed and applied in large evaluations using electronic health record review. This study confirmed high-quality supportive care, while identifying significant facility-level variation in VHA.

Funding Veterans Health Administration Office of Informatics and Analytics.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

WHO to push for public ban of e-cigarettes
MDedge Hematology and Oncology
Smokers not so welcome in the house anymore
MDedge Hematology and Oncology
Slightly more benefit from LDCT lung cancer screening in high-risk patients over 65
MDedge Hematology and Oncology
E-cigarettes don’t help cancer patients quit smoking
MDedge Hematology and Oncology
Long-term data allay concerns about using SBRT to treat early lung cancer
MDedge Hematology and Oncology
The art and science of cancer care
MDedge Hematology and Oncology
FDG-PET no help in differentiating cancer from benign lung nodules in infection-endemic regions
MDedge Hematology and Oncology
Thoracic radiotherapy improves outcomes in patients with extensive small cell lung cancer
MDedge Hematology and Oncology
VIDEO: Lung-MAP charts new ground in trial design
MDedge Hematology and Oncology
Adjuvant vaccine fails in NSCLC
MDedge Hematology and Oncology